We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.04B
AUM Growth
-$134M
Cap. Flow
-$160M
Cap. Flow %
-15.32%
Top 10 Hldgs %
17.93%
Holding
1,138
New
391
Increased
229
Reduced
281
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Financials 13.67%
3 Healthcare 9.75%
4 Industrials 9.11%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARMK icon
651
Aramark
ARMK
$14.8B
$20K ﹤0.01%
+781
New +$20.4K
LRMR icon
652
Larimar Therapeutics
LRMR
$428M
$20K ﹤0.01%
518
+386
+292% +$15.7K
MCRB icon
653
Seres Therapeutics
MCRB
$48.8M
$20K ﹤0.01%
+99
New +$21.6K
NTGR icon
654
NETGEAR
NTGR
$621M
$20K ﹤0.01%
368
-1,557
-81% -$83.2K
RGLS
655
DELISTED
Regulus Therapeutics
RGLS
$20K ﹤0.01%
+73
New +$23.7K
CMRX
656
DELISTED
Chimerix, Inc.
CMRX
$20K ﹤0.01%
4,321
+1,324
+44% +$6.25K
OTIC
657
DELISTED
Otonomy, Inc.
OTIC
$20K ﹤0.01%
+1,263
New +$21.1K
TLGT
658
DELISTED
Teligent, Inc
TLGT
$20K ﹤0.01%
+299
New +$21K
FRAN
659
DELISTED
Francesca's Holdings Corporation
FRAN
$20K ﹤0.01%
+94
New +$19.5K
PTLA
660
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$20K ﹤0.01%
+896
New +$17.5K
CDTX
661
DELISTED
Cidara Therapeutics
CDTX
$19K ﹤0.01%
+89
New +$18.5K
CLDX icon
662
Celldex Therapeutics
CLDX
$3.26B
$19K ﹤0.01%
+349
New +$19.9K
GNW icon
663
Genworth Financial
GNW
$3.68B
$19K ﹤0.01%
4,949
-4,610
-48% -$20.3K
MNKD icon
664
MannKind Corp
MNKD
$1.31B
$19K ﹤0.01%
+5,881
New +$17K
PCRX icon
665
Pacira BioSciences
PCRX
$1.01B
$19K ﹤0.01%
+590
New +$19.7K
RM icon
666
Regional Management Corp
RM
$303M
$19K ﹤0.01%
+710
New +$16.9K
EXPR
667
DELISTED
Express, Inc.
EXPR
$19K ﹤0.01%
+87
New +$21.4K
INSY
668
DELISTED
Insys Therapeutics, Inc.
INSY
$19K ﹤0.01%
+1,997
New +$22.6K
GK
669
DELISTED
G&K Services Inc
GK
$19K ﹤0.01%
193
-17
-8% -$1.63K
CROX icon
670
Crocs
CROX
$6.64B
$18K ﹤0.01%
+2,633
New +$20.4K
SLAB icon
671
Silicon Laboratories
SLAB
$7.23B
$18K ﹤0.01%
270
-954
-78% -$60K
FRBK
672
DELISTED
Republic First Bancorp Inc
FRBK
$18K ﹤0.01%
+2,200
New +$12.2K
NEOS
673
DELISTED
Neos Therapeutics, Inc
NEOS
$18K ﹤0.01%
+3,100
New +$21K
HABT
674
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$18K ﹤0.01%
+1,030
New +$15.8K
GD icon
675
General Dynamics
GD
$105B
$17K ﹤0.01%
100

Similar funds

Meeder Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Meeder Asset Management held 1,138 positions worth $1.04B, down 11% from $1.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management withdrew a net $160M in Q4 2016, closing 148 positions and reducing 281 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $74.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in iShares Core US Aggregate Bond ETF worth $17.1M.

  • Meeder Asset Management's largest Q4 2016 buy was iShares Core US Aggregate Bond ETF: 157,897 shares worth $17.1M.
  • Meeder Asset Management added most to Time Warner Inc in Q4 2016, an estimated $4.76M increase.
  • Meeder Asset Management's biggest Q4 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $43.5M.
  • Meeder Asset Management fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $74.7M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.04B portfolio in Q4 2016.
  • Meeder Asset Management opened 391 new positions and closed 148 in Q4 2016.
  • Meeder Asset Management's portfolio value fell 11% quarter-over-quarter to $1.04B.

Based on Meeder Asset Management's 13F filing for Q4 2016, filed 11 Jan 2017.